BiotechTube
Home/U.S. Stem Cell/Kristin Comella
KC

Kristin Comella

Former Chief Scientific Officer

U.S. Stem Cell

Therapeutic Areas

OrthopedicsNeurologyCardiologyAutoimmune Disorders

U.S. Stem Cell Pipeline

DrugIndicationPhase
Autologous Stem Cells for Osteoarthritis (Veterinary)Canine and Equine OsteoarthritisCommercial (Veterinary)
Autologous Stem Cells for Heart FailureCongestive Heart FailurePre-clinical
Autologous Stem Cells for Neurological DisordersALS, Traumatic Brain InjuryPre-clinical